Tc. Randall et al., Prolonged remission of recurrent, metastatic placental site trophoblastic tumor after chemotherapy, GYNECOL ONC, 76(1), 2000, pp. 115-117
Background. Placental site trophoblastic tumor (PSTT) is a form of gestatio
nal trophoblastic neoplasm that is frequently resistant to chemotherapy. In
most cases disease is confined to the uterus and can be cured by curettage
or simple hysterectomy. Patients with metastases, however, frequently have
progression of disease and die despite aggressive multiagent chemotherapy.
Case. A 31-year-old woman was found on review of uterine curettings to have
a PSTT. Imaging studies revealed multiple lung lesions, a liver lesion, an
d an enlarged irregular uterus. Hysterectomy and staging surgery revealed a
large tumor in the endometrial cavity and multiple metastases. She was tre
ated with etoposide-methotrexate-dactinomycin and cyclophosphamide-vincrist
ine and had a complete clinical remission. Six months later, however, she h
ad a recurrence. She was then treated with six cycles of etoposide-methotre
xate-dactinomycin and etoposide-cisplatin. Three years after completion of
the second regimen she is without evidence of disease.
Conclusion. Treatment with multiagent chemotherapy can produce long-term re
mission, even in patients with recurrent, metastatic PSTT. Addition of plat
inum may be helpful in patients who have recurred or progressed after treat
ment with non-platinum-containing regimens. (C) 2000 Academic Press.